BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1992260)

  • 1. Imaging modalities in recurrent head and neck tumors.
    Gussack GS; Hudgins PA
    Laryngoscope; 1991 Feb; 101(2):119-24. PubMed ID: 1992260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of contrast media in magnetic resonance tomography of head and neck tumors].
    Fürst G; Zamboglou N; Greven C; Kahn T; Mödder U
    Rofo; 1988 Nov; 149(5):489-95. PubMed ID: 2848280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MR tomography of the face and neck. Diagnostic value of MR, taking into account the use of gadolinium-DTPA, in comparison with CT].
    Heuck A; Reiser M; Wagner-Manslau C; Gmeinwieser J; Herzog M
    Rontgenpraxis; 1988 May; 41(5):155-61. PubMed ID: 3388138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preoperative diagnosis of neck tumors using magnetic resonance imaging].
    Nitsche N; Iro H
    HNO; 1989 Sep; 37(9):373-8. PubMed ID: 2808012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gd-DTPA in the diagnosis of brain metastasis].
    Kornienko VN; Pronin IN
    Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer.
    Kono M; Adachi S; Kusumoto M; Sakai E
    J Thorac Imaging; 1993; 8(1):18-26. PubMed ID: 8418316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional imaging in non-melanoma skin cancer of the head and neck.
    Lanka B; Turner M; Orton C; Carrington BM
    Clin Radiol; 2005 Aug; 60(8):869-77. PubMed ID: 16039922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo 31P magnetic resonance spectroscopy and MRI in patients with superficial tumors].
    Vogl T; Peer F; Reiman V; Holtmann S; Rennschmid C; Weber H; Hahn D; Lissner J
    Rofo; 1989 Jan; 150(1):58-65. PubMed ID: 2536498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of recurrent head and neck tumours following flap reconstructive surgery.
    Tomura N; Watanabe O; Hirano Y; Kato K; Takahashi S; Watarai J
    Clin Radiol; 2002 Feb; 57(2):109-13. PubMed ID: 11977942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging with Gd-DTPA in lesions of the head and neck.
    Vogl Th; Dresel S; Juergens M; Assal J; Lissner J
    J Otolaryngol; 1993 Aug; 22(4):220-30. PubMed ID: 8230372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging.
    Herrlin K; Ling LB; Pettersson H; Willén H; Rydholm A
    Acta Radiol; 1990 May; 31(3):233-6. PubMed ID: 2386637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gadolinium-DTPA in the evaluation of extracranial head and neck mass lesions.
    Crawford SC; Harnsberger HR; Lufkin RB; Hanafee WN
    Radiol Clin North Am; 1989 Mar; 27(2):219-42. PubMed ID: 2919230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.
    Mihara F; Gupta KL; Joslyn JN
    Radiat Med; 1994; 12(4):147-51. PubMed ID: 7809407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment imaging appearances in head and neck cancer patients.
    Offiah C; Hall E
    Clin Radiol; 2011 Jan; 66(1):13-24. PubMed ID: 21147294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging of head and neck.
    Razek AA
    J Comput Assist Tomogr; 2010; 34(6):808-15. PubMed ID: 21084893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: differentiation from recurrent or metastatic disease with MR imaging.
    Wu LA; Liu HM; Wang CW; Chen YF; Hong RL; Ko JY
    Radiology; 2012 Jul; 264(1):136-45. PubMed ID: 22495686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction.
    Hudgins PA; Burson JG; Gussack GS; Grist WJ
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1689-94. PubMed ID: 7847215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.